Less common risks include pancreatitis, gallbladder problems, allergic reactions, kidney issues, and possible thyroid tumors including cancer
Pain increases exposure and reinforcement
Some government-funded health systems are likely to make population-scale deals in the coming years, which could broaden access further
Long-term success follows systems, not just drugs: studies and program reports show roughly 75% of participants experience significant weight loss on GLP-1 medications, and about 60% maintain weight loss long term when behavioral anchors and monitoring are included, so tracking the first 8 to 12 weeks is critical
Ensure you drink plenty of fluids to avoid kidney problems, especially when starting treatment or increasing your dose
Q: When is the right time to schedule